Follow
Dr. Stephan Harm
Dr. Stephan Harm
University for Continuing Education Krems
Verified email at donau-uni.ac.at
Title
Cited by
Cited by
Year
Cytokine removal in extracorporeal blood purification: an in vitro study
S Harm, C Schildböck, J Hartmann
Blood Purification 49 (1-2), 33-43, 2020
662020
Pore size–a key property for selective toxin removal in blood purification
S Harm, D Falkenhagen, J Hartmann
The International journal of artificial organs 37 (9), 668-678, 2014
572014
Ex vivo investigation on internal tunnel approach/internal resin infiltration and external nanosilver-modified resin infiltration of proximal caries exceeding into dentin
AM Kielbassa, MR Leimer, J Hartmann, S Harm, M Pasztorek, IB Ulrich
PLoS One 15 (1), e0228249, 2020
422020
Endotoxin adsorbents in extracorporeal blood purification: do they fulfill expectations?
S Harm, D Falkenhagen, J Hartmann
The International journal of artificial organs 37 (3), 222-232, 2014
382014
Effective removal of estrogens from drinking water and wastewater by adsorption technology
J Hartmann, R Beyer, S Harm
Environmental Processes 1, 87-94, 2014
372014
Sorbent for endotoxins
D Falkenhagen, S Harm, J Hartmann, V Weber
US Patent 9,440,019, 2016
24*2016
An in vitro study on factors affecting endotoxin neutralization in human plasma using the Limulus amebocyte lysate test
S Harm, C Schildböck, K Strobl, J Hartmann
Scientific Reports 11 (1), 4192, 2021
232021
Low-dose polymyxin: an option for therapy of Gram-negative sepsis
S Harm, F Gabor, J Hartmann
Innate immunity 22 (4), 274-283, 2016
232016
The role of ionized calcium and magnesium in regional citrate anticoagulation and its impact on inflammatory parameters
K Strobl, S Harm, V Weber, J Hartmann
The International journal of artificial organs 40 (1), 15-21, 2017
212017
Blood compatibility—an important but often forgotten aspect of the characterization of antimicrobial peptides for clinical application
S Harm, K Lohner, U Fichtinger, C Schildböck, J Zottl, J Hartmann
International Journal of Molecular Sciences 20 (21), 5426, 2019
152019
Removal of stabilizers from human serum albumin by adsorbents and dialysis used in blood purification
S Harm, C Schildböck, J Hartmann
PLoS One 13 (1), e0191741, 2018
142018
Alginate-encapsulated human hepatoma C3A cells for use in a bioartificial liver device-the hybrid-MDS
S Harm, K Strobl, J Hartmann, D Falkenhagen
The International Journal of Artificial Organs 32 (11), 769-778, 2009
142009
Clearance of selected plasma cytokines with continuous veno-venous hemodialysis using ultraflux EMiC2 versus ultraflux AV1000S
T Eichhorn, J Hartmann, S Harm, I Linsberger, F König, G Valicek, ...
Blood purification 44 (4), 260-266, 2017
132017
Characterization of adsorbents for cytokine removal from blood in an in vitro model
S Harm, F Gabor, J Hartmann
Journal of Immunology Research 2015, 2015
132015
Removal of bile acids by extracorporeal therapies: an in vitro study
J Hartmann, S Harm
The International Journal of Artificial Organs 41 (1), 52-57, 2018
112018
ESICM LIVES 2016: part three: Milan, Italy. 1–5 October 2016
T Velasquez, G Mackey, J Lusk, UG Kyle, T Fontenot, P Marshall, ...
Intensive Care Medicine Experimental 4, 405-607, 2016
92016
Influence of citrate concentration on the activation of blood cells in an in vitro dialysis setup
J Gubensek, K Strobl, S Harm, R Weiss, T Eichhorn, J Buturovic-Ponikvar, ...
PLoS One 13 (6), e0199204, 2018
82018
Adsorption of the inflammatory mediator high-mobility group box 1 by polymers with different charge and porosity
C Tripisciano, T Eichhorn, S Harm, V Weber
BioMed Research International 2014, 2014
72014
Performance of lateral flow assays for SARS-CoV-2 compared to RT-qPCR
M Pilecky, S Harm, C Bauer, J Zottl, R Emprechtinger, T Eichhorn, ...
Journal of Infection 84 (4), 579-613, 2022
62022
A new integrated technique for the supportive treatment of sepsis
J Hartmann, S Harm
The International Journal of Artificial Organs 40 (1), 4-8, 2017
62017
The system can't perform the operation now. Try again later.
Articles 1–20